WDTN Dayton news: FDA approves first melanoma cellular therapy
The University of Cincinnati's Trisha Wise-Draper, MD, PhD, spoke with WDTN Dayton to discuss the approval of Amtagvi, the first cellular therapy for metastatic or unresectable melanoma, a harmful skin cancer.
“It’s actually a cellular therapy but its very different than the cellular therapies that are currently available for a lot of the hematologic malignancies,” said Wise-Draper, a University of Cincinnati Cancer Center member, section head of Medical Oncology and professor in the Division of Hematology/Oncology in UC’s College of Medicine.
The new therapy is for patients who have exhausted all other options.
“Because of the complicated nature of it, not everyone should get the therapy,” Wise-Draper said. “But for those that are fit and able to undergo the multiple treatments, cause it does require a very large multidisciplinary team.”
Wise-Draper said the Cancer Center's team of multidisciplinary experts will evaluate each patient to see if they are a fit for Amtagvi, since it is extensive.
“It’s really important that we evaluate the patient for feasibility upfront,” she said, “and make sure that’s something they’ll be able to undergo.”
Featured photo at top of Wise-Draper, left, and Vinita Takiar in their research laboratory. Photo/Colleen Kelley/UC Marketing + Brand
Related Stories
These teeny spiders are social media stars
August 28, 2026
The New York Times turned to a University of Cincinnati professor to explain the appeal of jumping spiders on social media.
An internal divide among unions on AI impacts the Wisconsin gubernatorial race
August 28, 2026
Anne Lofaso, a professor in the Donald P. Klekamp College of Law at UC, spoke with Wisconsin Public Radio, about the schism among unions over AI and whether it is a plus, a negative, or somewhere in between when looking at job creation.
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.